405
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

A Comparative Study on Immunomodulatory Activity of Polysaccharides from Two Official Species of Ganoderma (Lingzhi)

, , , , , & show all
Pages 1124-1131 | Received 29 Oct 2013, Accepted 12 Jun 2014, Published online: 10 Sep 2014

REFERENCES

  • Nie S, Zhang H, Li W, and Xie M: Current development of polysaccharides from Ganoderma: Isolation, structure and bioactivities. Bioact Carbohyd Diet Fibre 1, 10–20, 2013.
  • Chinese Pharmacopoeia Commission: Chinese Pharmacopoeia. China Medical Science Press, Beijing, China, 2010.
  • Liu Y, Qiu F, and Di X: Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species. J Pharm Biomed Anal 54, 717–721, 2011.
  • Liu YW, Gao JL, Guan J, Qian ZM, Feng K, et al.: Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem 57, 3087–3093, 2009.
  • Yan YZ, Xie PS, Lam WK, Chui E, and Yu QX: Study on triterpenoic acids distribution in Ganoderma mushrooms by automatic multiple development high performance thin layer chromatographic fingerprint analysis. J AOAC Int 93, 1384–1389, 2010.
  • Zhao J, Zhang XQ, Li SP, Yang FQ, Wang YT, et al.: Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography. J Sep Sci 29, 2609–2615, 2006.
  • Gao JL, Leung KSY, Wang YT, Lai CM, Li SP, et al.: Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. J Pharm Biomed Anal 44, 807–811, 2007.
  • Lv GP, Zhao J, Duan JA, Tang YP, and Li SP: Comparison of sterols and fatty acids in two species of Ganoderma. Chem Cent J 6, 10, 2012.
  • Yue GGL, Fung KP, Tse GMK, Leung PC, and Lau CBS: Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med 12, 777–789, 2006.
  • Cheng CH, Leung AY, and Chen CF: The effects of two different Ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells. Nutr Cancer 62, 648–658, 2010.
  • Boh B: Ganoderma lucidum: A potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov 8, 255–287, 2013.
  • Zhang S, Nie S, Huang D, Li W, and Xie M: Immunomodulatory effect of Ganoderma atrum polysaccharide on CT26 tumor-bearing mice. Food Chem 136, 1213–1219, 2013.
  • Li WJ, Chen Y, Nie SP, Xie MY, He M, et al.: Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response. J Cell Biochem 112, 860–871, 2011.
  • Liu Y, Li YF, Zheng KY, and Fei XF: Antitumor active protein-containing glycans from the body of Ganoderma tsugae. Chem Res Chin Univ 28, 449–453, 2012.
  • Ma J, Liu C, Chen Y, Jiang J, and Qin Z: Cellular and molecular mechanisms of the Ganoderma applanatum extracts induces apoptosis on SGC-7901 gastric cancer cells. Cell Biochem Funct 29, 175–182, 2011.
  • Jeong YT, Yang BK, Jeong SC, Kim SM, and Song CH: Ganoderma applanation: A promising mushroom for antitumor and immunomodulating activity. Phytother Res 22, 614–619, 2008.
  • Lin CH, Hsiao YM, Ou CC, Lin YW, Chiu YL, et al.: GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor α-induced expression of matrix metalloproteinase 9 via NF-κB pathway in human alveolar epithelial A549 cells. J Agric Food Chem 58, 12014–12021, 2010.
  • Hsin IL, Ou CC, Wu TC, Jan MS, Wu MF, et al.: GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells. Autophagy 7, 873–882, 2011.
  • Lin CH, Sheu GT, Lin YW, Yeh CS, Huang YH, et al.: A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochem 45, 1537–1542, 2010.
  • Wu GS, Guo JJ, Bao JL, Li XW, Chen XP, et al.: Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum—a review. Expert Opin Investig Drugs 22, 981–992, 2013.
  • Sliva D: Ganoderma lucidum in cancer research. Leukemia Res 30, 767–768, 2006.
  • Xu Z, Chen X, Zhong Z, Chen L, and Wang Y: Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. Am J Chin Med 39, 15–27, 2011.
  • Zhou X, Lin J, Yin Y, Zhao J, Sun X, et al.: Ganodermataceae: Natural products and their related pharmacological functions. Am J Chin Med 35, 559–574, 2007.
  • Sheena N, Lakshmi B, and Janardhanan KK: Therapeutic potential of Ganoderma lucidum (Fr.) P. Karst. Nat Prod Rad 4, 382–386, 2005.
  • Lin YL, Liang YC, Lee SS, and Chiang BL: Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-κB and p38 mitogen-activated protein kinase pathways. J Leukocyte Biol 78, 533–543, 2005.
  • Yeh CH, Chen HC, Yang JJ, Chuang WI, and Sheu F: Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem 58, 8535–8544, 2010.
  • Lai SW, Lin JH, Lai SS, and Wu YL: Influence of Ganoderma lucidum on blood biochemistry and immunocompetence in horses. Am J Chin Med 32, 931–940, 2004.
  • Lin ZB: Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99, 144–153, 2005.
  • Zhu XL, Chen AF, and Lin ZB: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 111, 219–226, 2007.
  • Yang G, Jiang RZ, Chen YH, Luo HM, Xu DD, et al.: Characterization and anti-tumor activity of glycopeptides from Ganoderma sinensis. Chem Res Chin Univ 25, 47–51, 2009.
  • Yang GH, Yang YF, and Jin JD: Antitumor fraction from liquid submerged fermentation of Ganoderma sinense. Chin Tradit Herbal Drugs 39, 877–880, 2008.
  • Han XQ, Chan BCL, Dong CX, Yang YH, Ko CH, et al.: Isolation, structure characterization, and immunomodulating activity of a hyperbranched polysaccharide from the fruiting bodies of Ganoderma sinense. J Agric Food Chem 60, 4276–4281, 2012.
  • Han XQ, Chan BCL, Yu H, Yang YH, Hu SQ, et al.: Structural characterization and immuno-modulating activities of a polysaccharide from Ganoderma sinense. Int J Biol Macromol 51, 597–603, 2012.
  • Yue GGL, Chan BCL, Han XQ, Cheng L, Wong ECW, et al.: Immunomodulatory activities of Ganoderma sinense polysaccharides in human immune cells. Nutr Cancer 65, 765–774, 2013.
  • Klimp AH, De Vries EGE, Scherphof GL, and Daemen T: A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol/Hematol 44, 143–161, 2002.
  • Zhang J, Tang Q, Zhou C, Jia W, Da Silva L, et al.: GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci 87, 628–637, 2010.
  • Zhao L, Dong Y, Chen G, and Hu Q: Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr Polym 80, 783–789, 2010.
  • Dubois M, Gilles KA, Hamilton JK, Rebers PA, and Smith F: Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350–356, 1956.
  • Xie J, Zhao J, Hu DJ, Duan JA, Tang YP, et al.: Comparison of polysaccharides from two species of Ganoderma. Molecules 17, 740–752, 2012.
  • Guan J, Yang FQ, and Li SP: Evaluation of carbohydrates in natural and cultured Cordyceps by pressurized liquid extraction and gas chromatography coupled with mass spectrometry. Molecules 15, 4227–4241, 2010.
  • Bonavida B, Baritaki S, Huerta-Yepez S, Vega MI, Chatterjee D, et al.: Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide 19, 152–157, 2008.
  • Steinkamp JA, Wilson JS, Saunders GC, and Stewart CC: Phagocytosis: Flow cytometric quantitation with fluorescent microspheres. Science 215, 64–66, 1982.
  • Onozaki K, Matsushima K, Aggarwal BB, and Oppenheim JJ: Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135, 3962–3968, 1985.
  • Lachman LB, Dinarello CA, Llansa ND, and Fidler IJ: Natural and recombinant human interleukin 1-β is cytotoxic for human melanoma cells. J Immunol 136, 3098–3102, 1986.
  • Braddock M and Quinn A: Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3, 330–339, 2004.
  • Houssiau F and Van Snick J: IL6 and T-cell response. Res Immunol 143, 740–743, 1992.
  • Mocellin S, Marincola FM, and Young HA: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukocyte Biol 78, 1043–1051, 2005.
  • Dennis KL, Blatner NR, Gounari F, and Khazaie K: Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol 25, 637–645, 2013.
  • Van Horssen R, Ten Hagen TLM, and Eggermont AMM: TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11, 397–408, 2006.
  • Gao Y, Zhou S, Jiang W, Huang M, and Dai X: Effects of Ganopoly® (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32, 201–215, 2003.
  • Aderem A and Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev 17, 593–623, 1999.
  • Chokri M, Freudenberg M, Galanos C, Poindron P, and Bartholeyns J: Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 9, 1185–1190, 1989.
  • Kuo HP, Wang CH, Huang KS, Lin HC, Yu CT, et al.: Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med 161, 192–199, 2000.
  • Hill JR, Corbett JA, Kwon G, Marshall CA, and McDaniel ML: Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 271, 22672–22678, 1996.
  • Eigler A, Sinha B, and Endres S: Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196, 494–501, 1993.
  • Zhang M, Cui SW, Cheung PCK, and Wang Q: Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Tech 18, 4–19, 2007.
  • Guan J and Li SP: Discrimination of polysaccharides from traditional Chinese medicines using saccharide mapping-Enzymatic digestion followed by chromatographic analysis. J Pharm Biomed Anal 51, 590–598, 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.